Survival Lower for Children With Leukemia Living on Texas-Mexico Border
TUESDAY, Feb. 21, 2023 (HealthDay News) — For children with acute lymphoblastic leukemia (ALL), but not those with acute myeloid leukemia (AML), living along the Texas-Mexico border is associated with inferior survival, according to a study published…
Learn MoreAllogeneic Stem Cell Transplant Feasible for Leukemia in Elderly Patients
TUESDAY, Feb. 21, 2023 (HealthDay News) — In elderly adults aged 60 years and older with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS), allogeneic hematopoietic stem cell transplant (HSCT) can be performed with acceptable overall sur…
Learn MoreFDA Approves New Drug for Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
MONDAY, Jan. 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved zanubrutinib (Brukinsa), a next-generation BTK inhibitor, for the treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.The ap…
Learn More2022 ICC Recategorization Facilitates Risk Stratification of Myelodysplastic Syndrome
THURSDAY, Jan. 19, 2023 (HealthDay News) — Clinical characteristics, outcomes, and genetic features vary among different myelodysplastic syndrome (MDS) subtypes categorized using the 2022 International Consensus Classification (ICC), according to a s…
Learn MoreInflammation Linked to Inferior Outcomes in Leukemia
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — A unique inflammation signature, in which atypical B cells are identified, is associated with worse outcomes in patients with acute myeloid leukemia (AML), according to a study published online Jan. 11 in N…
Learn MoreDelay in Time to Antibiotics Permissible for Inpatient Neutropenic Fever
MONDAY, Jan. 9, 2023 (HealthDay News) — For patients with hematologic malignancy who develop inpatient neutropenic fever, delays in time to antibiotics do not significantly affect overall survival at 180 days, according to a study published in the Ja…
Learn MoreProgression-Free Survival Increased With Zanubrutinib in Leukemia
TUESDAY, Jan. 3, 2023 (HealthDay News) — Progression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), according t…
Learn MorePatient-Centered Communication Tool Feasible for Seniors With Acute Myeloid Leukemia
THURSDAY, Dec. 22, 2022 (HealthDay News) — Incorporation of an innovative patient-centered communication tool (UR-GOAL tool) is feasible for older adults with newly diagnosed acute myeloid leukemia (AML), according to study published online Dec. 19 i…
Learn MoreSingle-Tube Multiparametric Flow Cytometry Predicts Treatment Response in Leukemia
WEDNESDAY, Dec. 21, 2022 (HealthDay News) — A single-tube eight-color multiparametric flow cytometry (MFC) panel has good sensitivity for minimal/measurable residual disease (MRD) and excellent prediction for survival among patients with B-cell acute…
Learn MoreAmerican Society of Hematology, Dec. 10 to 13
The annual meeting of the American Society of Hematology was held from Dec. 10 to 13 in New Orleans and attracted participants from around the world, including hematology specialists as well as clinical practitioners and other health care professiona…
Learn More